Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Latest US "SHORT report", better, still majority of US trade

View:

Post by SouthernTierTom on Jan 14, 2022 5:44pm

Latest US "SHORT report", better, still majority of US trade

Historical Short Volume Data for TLTFF

Date	Close	High	Low	Volume	Short Volume	% of Vol Shorted
Jan 13	NA	NA	NA	92,285	65,535	71.01
Jan 12	NA	NA	NA	115,840	104,240	89.99
Jan 11	NA	NA	NA	200,053	179,879	89.92
Jan 10	NA	NA	NA	31,171	8,271	26.53
Jan 07	NA	NA	NA	133,365	25,475	19.10
Jan 06	NA	NA	NA	56,346	5,150	9.14
Jan 05	NA	NA	NA	104,340	83,040	79.59
Jan 04	NA	NA	NA	166,550	143,250	86.01
Jan 03	NA	NA	NA	60,147	40,147	66.75
Dec 31	NA	NA	NA	250,826	95,581	38.11
Dec 30	NA	NA	NA	233,194	156,657	67.18
Dec 29	NA	NA	NA	135,995	35,295	25.95
Dec 28	NA	NA	NA	135,188	122,897	90.91
Dec 27	NA	NA	NA	8,212	6,158	74.99
Dec 23	NA	NA	NA	58,028	26,528	45.72
Dec 22	NA	NA	NA	44,300	21,000	47.40
Dec 21	NA	NA	NA	9,732	3,932	40.40
Dec 20	NA	NA	NA	128,470	31,367	24.42
Dec 17	NA	NA	NA	91,420	46,320	50.67
Dec 16	NA	NA	NA	157,242	80,209	51.01
Dec 15	NA	NA	NA	201,204	163,221	81.12

565

Comment

Comment by SouthernTierTom on Jan 15, 2022 11:46am

Shorting here in the US at 84% yesterday. Will post actual numbers later Keep up the great posting fellas!

745

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password